These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
    Author: Belmatoug N, Azorin M, Huten D, de Villemeur TB, Carbon C.
    Journal: Rev Med Interne; 1993; 14(10):996. PubMed ID: 8009089.
    Abstract:
    Gaucher's disease is caused by a deficiency of glucocerebrosidase. Enzyme replacement therapy with glucocerebrosidase (Ceredase) is available in France since 1991. We report the clinical effectiveness in a woman with type 1 Gaucher's disease treated with the enzyme for one year. Hepatomegaly regressed, bone pain decreased but improvement of severe skeletal manifestations were slow and incomplete.
    [Abstract] [Full Text] [Related] [New Search]